Sara Carmen

USPTO Granted Patents = 8 (Patent Applications = 6)

CIPO Patents = 1 (Patent Applications = 2)

EPO Patents = 2 (Patent Applications = 7)

Average Co-Inventor Count = 19.3

ph-index = 3

Forward Citations = 416(Granted Patents)

Company Filing History:

Abb Vie Deutschland Gmbh & Co. Kg

patents

Years Active: 2005-2023

Loading Chart...

8 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 11738081 - Polynucleotides encoding IL33 antibodies and methods of using the same (2023-08-29),

2. 10668150 - IL33 form, mutated forms of IL33, antibodies, assays and methods of using the same (2020-06-02),

3. 9035030 - Human antibodies that bind the P40 subunit of human IL-12 and methods for using the same (2015-05-19),

4. 8865174 - Methods of treatment using human antibodies that bind IL-12 (2014-10-21),

5. 8765918 - Human antibodies that bind human interleukin-12 (2014-07-01),

6. 7883704 - Methods for inhibiting the activity of the P40 subunit of human IL-12 (2011-02-08),

7. 7504485 - Human antibodies that bind human IL-12 (2009-03-17),

8. 6914128 - Human antibodies that bind human IL-12 and methods for producing (2005-07-05),

Title: Unveiling the Innovative Spirit of Sara Carmen

Introduction:

Sara Carmen, a brilliant inventor hailing from Cambridge, UK, has made significant strides in the field of biotechnology and healthcare. With a keen eye for detail and a passion for innovation, she has garnered a remarkable reputation in the realm of patents and inventions.

Latest Patents:

Sara Carmen's latest patents showcase her expertise in developing groundbreaking solutions for immune and inflammatory disorders. Her inventions include polynucleotides encoding IL33 antibodies, mutated forms of IL33, and methods for modulating cytokine activity. These patents highlight her dedication to advancing medical treatments and improving patient outcomes.

Career Highlights:

Throughout her career, Sara Carmen has made valuable contributions to companies such as Abbott GmbH & Co. KG and MedImmune Limited. Her innovative spirit and problem-solving abilities have led to the successful development of novel therapeutic approaches and diagnostic tools within these organizations.

Collaborations:

Sara Carmen has had the pleasure of working alongside esteemed colleagues such as Jochen G. Salfeld and Michael Roguska. Together, they have formed dynamic teams that have pushed the boundaries of scientific research and development, ultimately leading to the creation of impactful inventions.

Conclusion:

In conclusion, Sara Carmen's unwavering commitment to innovation and her insatiable curiosity have solidified her position as a respected figure in the world of patents and inventions. Her inventive spirit continues to drive progress in the field of biotechnology, offering hope for improved healthcare solutions in the future.

This text is generated by artificial intelligence and may not be accurate.